探讨应用阿托伐他汀治疗亚急性硬膜下血肿的疗效及安全性

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (30 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Atorvastatin in the treatment of subacute subdural hematoma.Methods A total of 50 patients with subacute subdural hematoma in our hospital from March 2017 to March 2019 were divided into the observation group and the control group according to the digital parity method, 25 cases in each group.The control group was drilled at the thickest part of the skull hematoma, and the observation group was treated with Atorvastatin.The therapeutic effect, adverse reactions and recurrence, neurological function score and activity of daily life score of the two groups were compared.Results The total effective rate of the observation group was higher than that of the control group, the rates of adverse reactions and recurrence were lower than those of the control group, and the scores of neurological function and activities of daily life after treatment were lower than that of the control group,the differences were statistically significant (P＜0.05).Conclusion Atorvastatin is not only effective in the treatment of subacute subdural hematoma, but also can reduce the incidence of adverse reactions, reduce the recurrence rate, improve the neurological function, and improve the ability of daily life, which has significant clinical value.

Key words： Atorvastatin Subacute subdural hematoma Disease recurrence Neurological function Activity of daily living Safety

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HUANG An-jin

Cite this article:

HUANG An-jin. Investigation on the efficacy and safety of Atorvastatin in the treatment of subacute subdural hematoma[J]. 中国当代医药, 2020, 27(13): 37-39.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I13/37

[1]	秦晓雅，万力源，赵晓平，等.阿托伐他汀辅助手术治疗慢性硬膜下血肿临床疗效的Meta 分析[J].实用心脑肺血管病杂志，2019，27（8）：26-30.
[2]	卢峰，林世水，魏德.阿托伐他汀钙片配合负压密闭钻孔引流治疗慢性硬膜下血肿的效果分析[J].中国当代医药，2016，23（9）：51-53.
[3]	王磊，浦志一.钻孔引流术联合术后口服阿托伐他汀钙片治疗慢性硬膜下血肿的临床疗效[J].当代医学，2019，25（22）：165-167.
[4]	张朋.阿托伐他汀钙辅助治疗对慢性硬膜下血肿患者术后神经功能及复发率的影响[J].河南医学研究，2019，28（14）：2599-2600.
[5]	官春城，郭铭，梁晓华，等.阿托伐他汀联合微创置管引流术与单纯行微创置管引流术治疗慢性硬膜下血肿患者的疗效比较[J].实用中西医结合临床，2019，19（7）：3-5.
[6]	汪棋笙，侯黎明，李振，等.不冲洗钻孔引流联合阿托伐他汀治疗慢性硬膜下血肿的临床应用[J].系统医学，2019，4（13）：1-3.
[7]	黎华清，陈志生，黎志洲.阿托伐他汀治疗慢性硬膜下血肿术后残血的效果[J].中国当代医药，2018，25（2）：88-90.
[8]	刘强，庞绍铮.慢性硬膜下血肿术后应用阿托伐他汀降低复发的效果分析[J].江苏医药，2019，45（5）：534-535.
[9]	孙广升，王燕.阿托伐他汀钙对改善慢性硬膜下血肿出血量及神经功能的价值[J].中外医疗，2019，38（14）：23-25.
[10]	王衍廷，王小刚，王天助，等.微创钻孔引流与阿托伐他汀钙治疗慢性硬膜下血肿临床分析[J].中国实用神经疾病杂志，2019，22（5）：479-486.
[11]	罗成焕，罗伟鹏，王沃.钻孔引流术联合阿托伐他汀治疗慢性硬膜下血肿疗效观察[J].海南医学，2019，30（5）：591-593.
[12]	徐涛.不同种类他汀药物对慢性硬膜下血肿治疗的临床效果[J].中国现代医生，2019，26（5）：86-88.
[13]	杨力军，宋光太，杨凯，等.三联疗法治疗慢性硬膜下血肿的疗效分析[J].现代实用医学，2019，31（1）：82-83.
[14]	刘鹏，王智浩，周雷升，等.钻孔引流术联合阿托伐他汀治疗慢性硬膜下血肿的临床效果[J].临床医学研究与实践，2019，4（2）：55-57.
[15]	黄晓斌.阿托伐他汀治疗慢性硬膜下血肿的效果观察[J].临床合理用药杂志，2018，11（34）：67-69.